Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, Carlo, Lee, Virginia M.-Y., Trojanowski, John Q.·2007·Nature Reviews Neuroscience

Cited by (1,013)

Items 701–800 of 1,013

  1. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson’s and Alzheimer’s Diseases
    Yoav Atsmon‐Raz, Yifat Miller · 2015 · ACS Chemical Neuroscience
  2. Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
    Michael G. Agadjanyan, Karen Zagorski, Irina Petrushina, Hayk Davtyan, Konstantin Kazarian, Maxim Antonenko, Joy L. Davis, Charles Bon, Mathew M. Blurton-Jones, David H. Cribbs et al. · 2017 · Molecular Neurodegeneration
  3. Brain Under Stress and Alzheimer’s Disease
    Boris Mravec, Ľubica Horváthová, Alexandra Padová · 2017 · Cellular and Molecular Neurobiology
  4. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils
    Gibbons, Garrett S., Banks, Rachel A., Kim, Bumjin, Xu, Hong, Changolkar, Lakshmi, Leight, Susan N., Riddle, Dawn M., Li, Chi, Gathagan, Ronald J., Brown, Hannah J. et al. · 2017 · The Journal of Neuroscience
  5. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells
    Sebastian P. Pernal, Victoria Wu, Vuk Uskoković · 2017 · ACS Applied Materials & Interfaces
  6. Loss of Hrs in the Central Nervous System Causes Accumulation of Ubiquitinated Proteins and Neurodegeneration
    Keiichi Tamai, Masafumi Toyoshima, Nobuyuki Tanaka, Noriko Yamamoto, Yuji Owada, Hiroshi Kiyonari, Kazuko Murata, Yoshiyuki Ueno, Masao Ono, Tooru Shimosegawa et al. · 2008 · American Journal Of Pathology
  7. Cross-β Polymerization of Low Complexity Sequence Domains
    Masato Kato, Steven Lanier McKnight · 2016 · Cold Spring Harbor Perspectives in Biology
  8. The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
    Jean‐Philippe Courade, Henrik Zetterberg, Günter U. Höglinger, Ilse Dewachter · 2025 · Cell
  9. Older and wiser? An affective science perspective on age-related challenges in financial decision making
    Mariann R. Weierich, Elizabeth A. Kensinger, Alicia Haydock Munnell, Steven A. Sass, Bradford Clark Dickerson, Christopher I. Wright, Lisa Feldman Barrett · 2010 · Social Cognitive and Affective Neuroscience
  10. A Smart Near-Infrared Fluorescence Probe for Selective Detection of Tau Fibrils in Alzheimer’s Disease
    Yujin Seo, Kwang‐Su Park, Taewoong Ha, Mi Kyoung Kim, Yu Jin Hwang, Jung-Hee Lee, Hoon Ryu, Hyunah Choo, Youhoon Chong · 2016 · ACS Chemical Neuroscience
  11. Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders
    Rakez Kayed, George R. Jackson · 2009 · Current Opinion in Immunology
  12. Neurodegenerative diseases: exercising towards neurogenesis and neuroregeneration
    Eng‐Tat Ang · 2010 · Frontiers in Aging Neuroscience
  13. Curcumin: a natural substance with potential efficacy in Alzheimer’s disease
    Pamela E. Potter · 2013 · Journal of Experimental Pharmacology
  14. The Cu(II)/Aβ/Human Serum Albumin Model of Control Mechanism for Copper-Related Amyloid Neurotoxicity
    Małgorzata Rózga, Wojciech Bal · 2009 · Chemical Research in Toxicology
  15. Mitoxantrone Analogues as Ligands for a Stem−Loop Structure of Tau Pre-mRNA
    Yang Liu, Eleanor Peacey, John R. Dickson, Christine P. Donahue, Suxin Zheng, Gabriele Varani, Michael S. Wolfe · 2009 · Journal of Medicinal Chemistry
  16. Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding
    Chad J. Leugers, Gloria S. Lee · 2010 · Journal of Biological Chemistry
  17. Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
    Vishruti S. Makani, Bin Zhang, Heeoon Han, Yuemang Yao, Pierrik Lassalas, Kevin Lou, Ian Paterson, Virginia M.‐Y. Lee, John Q. Trojanowski, Carlo Ballatore et al. · 2016 · Acta Neuropathologica Communications
  18. Soluble Tau has devastating effects on the structural plasticity of hippocampal granule neurons
    Marta Bolós, Noemí Pallas‐Bazarra, Julia Terreros‐Roncal, Juan Ramón Perea, Jerónimo Jurado‐Arjona, Jesús Ávila, Marı́a Llorens-Martı́n · 2017 · Translational Psychiatry
  19. Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling
    Xing‐sheng Shu, Yilin Zhang, Meiqi Li, Xiaoyan Huang, Yangfan Yang, Junhui Zeng, Yingying Zhao, Xiaomei Wang, Weizhen Zhang, Ying Ying · 2019 · Neuropharmacology
  20. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262
    Taro Saito, Toshiya Oba, Sawako Shimizu, Akiko Asada, Koichi Iijima, Kanae Ando · 2019 · Human Molecular Genetics
  21. Independent tubulin binding and polymerization by the proline-rich region of Tau is regulated by Tau's N-terminal domain
    Kristen M. McKibben, Elizabeth R. Rhoades · 2019 · Journal of Biological Chemistry
  22. Tau Propagation as a Diagnostic and Therapeutic Target for Dementia: Potentials and Unanswered Questions
    Shuko Takeda · 2019 · Frontiers in Neuroscience
  23. Misfolding and Self-Assembly Dynamics of Microtubule-Binding Repeats of the Alzheimer-Related Protein Tau
    Huan He, Yuying Liu, Yunxiang Sun, Feng Ding · 2021 · Journal of Chemical Information and Modeling
  24. PROTAC technology for the treatment of Alzheimer’s disease: advances and perspectives
    Hiroyuki Inuzuka, Jing Liu, Wenyi Wei, Abdol-Hossein Rezaeian · 2022 · Acta Materia Medica
  25. Selective loss of glycogen synthase kinase-3α in birds reveals distinct roles for GSK-3 isozymes in tau phosphorylation
    Lina Tsaadon Alon, Shmuel Pietrokovski, Shay Barkan, Limor Avrahami, Oksana Kaidanovich‐Beilin, James Robert Woodgett, Anat Barnea, Hagit Eldar-Finkelman · 2011 · FEBS Letters
  26. Metal Nanoparticles in Alzheimer’s Disease
    Behera, Anindita, Sa, Nishigandha, Pradhan, Sweta Priyadarshini, Swain, Sunsita, Sahu, Pratap Kumar · 2023 · Journal of Alzheimer's Disease Reports
  27. Calcium phosphatase calcineurin influences tau metabolism
    Celeste M M. Karch, Amanda T. Jeng, Alison Goate · 2012 · Neurobiology of Aging
  28. Early‐onset axonal pathology in a novel P 301 S ‐ T au transgenic mouse model of frontotemporal lobar degeneration
    Janet van Eersel, Claire H. Stevens, Magdalena Przybyla, Amadeus Gladbach, Kristie Stefanoska, Chesed Chan, Wei‐Yi Ong, John R. Hodges, Greg Trevor Sutherland, Jillian J. Kril et al. · 2015 · Neuropathology and Applied Neurobiology
  29. Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics
    Yahui Liu, Hong Qing, Yulin Deng · 2014 · International Journal of Molecular Sciences
  30. Relative Resistance of Cdk5-phosphorylated CRMP2 to Dephosphorylation
    Adam R. Cole, Marc P. M. Soutar, Makoto Rembutsu, Lidy van Aalten, C. James Hastie, Hilary McLauchlan, Mark W. Peggie, Martin Balaštík, Kun Ping Lu, Calum D. Sutherland · 2008 · Journal of Biological Chemistry
  31. Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation
    Carlo Ballatore, Kurt R. Brunden, Francesco Piscitelli, Michael J. James, Alex Crowe, Yuemang Yao, Edward G. Hyde, John Q. Trojanowski, Virginia M.‐Y. Lee, Amos B. Smith · 2010 · Journal of Medicinal Chemistry
  32. JNK Inhibitors As Anti-Inflammatory and Neuroprotective Agents
    Piotr P. Graczyk · 2013 · Future Medicinal Chemistry
  33. Pseudohyperphosphorylation Causing AD-like Changes in Tau Has Significant Effects on Its Polymerization
    Qian Sun, T.C. Gamblin · 2009 · Biochemistry
  34. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APPswe/PS1ΔE9 transgenic mouse model of Alzheimer’s disease
    Jun Tang, Min Song, Yanyan Wang, Xiaotang Fan, Haiwei Xu, Yun Bai · 2009 · Biochemical and Biophysical Research Communications
  35. Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms
    Mahadevabharath R. Somayaji, Andrzej J. Przekwas, Raj K. Gupta · 2017 · Current Neuropharmacology
  36. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer’s disease-type pathologies in SAMP8 mice
    Zhen Zhang, Jingyu Yang, Chen Liu, Jun Xie, Shi Qiu, Xue Yang, Chunfu Wu · 2018 · Pharmacological Research
  37. Renin-Angiotensin System and Alzheimer’s Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives
    Victor Teatini Ribeiro, Leonardo Cruz de Souza, Ana Cristina Simões e Silva · 2019 · Protein and Peptide Letters
  38. Recent developments of small molecule γ-secretase modulators for Alzheimer's disease
    Shekar Mekala, Grady L. Nelson, Yue‐Ming Li · 2020 · RSC Medicinal Chemistry
  39. Brain metabolism and Alzheimer's disease: The prospect of a metabolite-based therapy
    Sean C. Thomas, Azhar A. Alhasawi, Vasu D. Appanna, C. Auger, Vasu D. Appanna · 2014 · The journal of nutrition health & aging
  40. Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAUP301L double-transgenic mice
    Lili C. Kudo, Liubov V. Parfenova, Guijie Ren, Nancy Vi, Maria Po-Ping Hui, Zhongcai Ma, Kimbley Lau, Michelle Gray, Fawzia Bardag‐Gorce, Martina Wiedau‐Pazos et al. · 2011 · Human Molecular Genetics
  41. Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease
    Sullivan, Sarah E., Young-Pearse, Tracy L. · 2017 · Brain Research
  42. Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery
    Bernard-Gauthier, Vadim, Mossine, Andrew V., Knight, Ashley, Patnaik, Debasis, Zhao, Wen-Ning, Cheng, Chialin, Krishnan, Hema S., Xuan, Lucius L., Chindavong, Peter S., Reis, Surya A. et al. · 2019 · Journal of Medicinal Chemistry
  43. The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
    Huang, Wendi, Huang, Juan, Huang, Nanqu, Luo, Yong · 2023 · Frontiers in Cell and Developmental Biology
  44. Oleanolic acid protects against cognitive decline and neuroinflammation-mediated neurotoxicity by blocking secretory phospholipase A2 IIA-activated calcium signals
    Leguo Zhang, Ruixue Xia, Jianpu Jia, Lixuan Wang, Kuo Li, Yanhua Li, Junling Zhang · 2018 · Molecular Immunology
  45. Alzheimer’s Disease, Anesthesia, and Surgery: A Clinically Focused Review
    Miles Berger, James R. Burke, Roderic G. Eckenhoff, Joseph P. Mathew · 2014 · Journal of Cardiothoracic and Vascular Anesthesia
  46. Inhibition of HDAC6 Modifies Tau Inclusion Body Formation and Impairs Autophagic Clearance
    Janina Leyk, Olaf Goldbaum, Monika Noack, Christiane Richter‐Landsberg · 2014 · Journal of Molecular Neuroscience
  47. Role of S5b/PSMD5 in Proteasome Inhibition Caused by TNF-α/NFκB in Higher Eukaryotes
    Sang Mi Shim, Won‐Jae Lee, Youngdoo Kim, Jong Wook Chang, Sungmin Song, Yong‐Keun Jung · 2012 · Cell Reports
  48. Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing
    Eleanor Peacey, Lilia Cristina De la Cruz Rodríguez, Yang Liu, Michael S. Wolfe · 2012 · Nucleic Acids Research
  49. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease
    Hye-Jin Park, Kang-Woo Lee, Stephanie E. Oh, Run Yan, Jie Zhang, Thomas G. Beach, Charles H. Adler, Michael V. Voronkov, Steven P. Braithwaite, Jeffry B. Stock et al. · 2017 · Journal of Neuropathology & Experimental Neurology
  50. Phosphorylation of the Amyloid-Beta Peptide Inhibits Zinc-Dependent Aggregation, Prevents Na,K-ATPase Inhibition, and Reduces Cerebral Plaque Deposition
    Evgeny P. Barykin, Irina Yu. Petrushanko, Sergey A. Kozin, Georgy B. Telegin, А. С. Чернов, O. D. Lopina, Sergey P. Radko, Vladimir A. Mitkevich, Alexander А. Makarov · 2018 · Frontiers in Molecular Neuroscience
  51. Aberrant functional connectivity network in subjective memory complaint individuals relates to pathological biomarkers
    Alzheimer’s Disease Neuroimaging Initiative, Kaicheng Li, Xiao Luo, Qingze Zeng, Yeerfan Jiaerken, Xiaojun Xu, Peiyu Huang, Zhujing Shen, Jingjing Xu, Chao Wang et al. · 2018 · Translational Neurodegeneration
  52. N‐homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia
    Carine Bossenmeyer‐Pourié, A. David Smith, Sylvain Lehmann, Vincent Deramecourt, Bernard Sablonnière, Jean‐Michel Camadro, Grégory Pourié, Racha Kerek, Déborah Helle, Rémy Umoret et al. · 2019 · The Journal of Pathology
  53. In vivo binding of a tau imaging probe, [11C]PBB3, in patients with progressive supranuclear palsy
    Hironobu Endo, Hitoshi Shimada, Naruhiko Sahara, Maiko Ono, Shunsuke Koga, Soichiro Kitamura, Fumitoshi Niwa, Shigeki Hirano, Yasuyuki Kimura, Masanori Ichise et al. · 2019 · Movement Disorders
  54. Role of Endoplasmic Reticulum Stress and Unfolded Protein Responses in Health and Diseases
    Abbas Ali Mahdi, Syed Husain Mustafa Rizvi, Arshiya Parveen · 2015 · Indian Journal of Clinical Biochemistry
  55. Searching for new animal models of Alzheimer′s disease
    Roberta Epis, Fabrizio Gardoni, Elena E. Marcello, Armando A. Genazzani, Pier Luigi Canonico, Mónica Di Luca · 2009 · European Journal of Pharmacology
  56. A Polymorphic Antioxidant Response Element Links NRF2/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders
    Wang, Xuting, Campbell, Michelle R., Lacher, Sarah E., Cho, Hye-Youn, Wan, Ma, Crowl, Christopher L., Chorley, Brian N., Bond, Gareth L., Kleeberger, Steven R., Slattery, Matthew et al. · 2016 · Cell Reports
  57. Intercommunication between metal ions and amyloidogenic peptides or proteins in protein misfolding disorders
    Jong‐Min Suh, Mingeun Kim, Jeasang Yoo, Jiyeon Han, Cinthya Paulina, Mi Hee Lim · 2022 · Coordination Chemistry Reviews
  58. Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.
    Zheng, Ping, Shultz, Sandy R., Hovens, Chris M., Velakoulis, Dennis, Jones, Nigel C., O’Brien, Terence J. · 2014 · Molecular Neurobiology
  59. Inflammation and neurodegenerative disorders
    Bernhard Theodor Baune · 2015 · Current Opinion in Psychiatry
  60. Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation
    Diana A.T. Nijholt, Anna Nölle, Elise S. van Haastert, Hessel Edelijn, Ruud F. G. Toonen, Jeroen J.M. Hoozemans, Wiep Scheper · 2013 · Neurobiology of Aging
  61. The Pre-Eclampsia Gene STOX1 Controls a Conserved Pathway in Placenta and Brain Upregulated in Late-Onset Alzheimer's Disease
    Marie van Dijk, Jan S. M. van Bezu, Ankie Poutsma, Robert Veerhuis, Annemieke J.M. Rozemüller, Wiep Scheper, Marinus A. Blankenstein, Cees B.M. Oudejans · 2010 · Journal of Alzheimer s Disease
  62. Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
    Christina Dammers, Deniz Yolcu, Laura Kukuk, Dieter Willbold, Marcus Pickhardt, Eckhard Mandelkow�, Anselm H. C. Horn, Heinrich Sticht, Marwa Malhis, Nadja Will et al. · 2016 · PLoS ONE
  63. Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?
    Melanie Dani, David James Brooks, Paul Edison · 2017 · Ageing Research Reviews
  64. Biomarkers in the Diagnosis and Prognosis of Alzheimer’s Disease
    Cole Schaffer, Nakia Sarad, Ashton DeCrumpe, Disha Goswami, Sara Herrmann, Jose Morales, Parth Patel, Jim Osborne · 2014 · SLAS TECHNOLOGY
  65. Proteomic analysis of postsynaptic density in Alzheimer's Disease
    Jianying Zhou, Drew R. Jones, Duc Minh Duong, Allan I. Levey, James J. Lah, Junmin Peng · 2013 · Clinica Chimica Acta
  66. A Comparative Study of Five Mouse Models of Alzheimer′s Disease: Cell Cycle Events Reveal New Insights into Neurons at Risk for Death
    Luming Li, Timmy Cheung, Jianmin Chen, Karl Herrup · 2011 · International Journal of Alzheimer s Disease
  67. Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors
    Lars Messing, Jochen Martin Decker, Maria Joseph, Eckhard Mandelkow�, Eva-Maria Mandelkow · 2012 · Neurobiology of Aging
  68. Microtubule‐Binding R3 Fragment from Tau Self‐Assembles into Giant Multistranded Amyloid Ribbons
    Jozef Adamčík, Antoni Sánchez‐Ferrer, Nadine Ait‐Bouziad, Nicholas P. Reynolds, Hilal Ahmed Lashuel, Raffaele Mezzenga · 2015 · Angewandte Chemie International Edition
  69. FcγRIIb-SHIP2 axis links Aβ to tau pathology by disrupting phosphoinositide metabolism in Alzheimer's disease model
    Tae‐In Kam, Hyejin Park, Youngdae Gwon, Sungmin Song, Seo-Hyun Kim, Seo Won Moon, Dong‐Gyu Jo, Yong‐Keun Jung · 2016 · eLife
  70. Isoform-independent and -dependent phosphorylation of microtubule-associated protein tau in mouse brain during postnatal development
    Dilina Tuerde, Taeko Kimura, Tomohiro Miyasaka, Kotaro Furusawa, Aki Shimozawa, Masato Hasegawa, Kanae Ando, Shin‐ichi Hisanaga · 2017 · Journal of Biological Chemistry
  71. Phase Separation and Cytotoxicity of Tau are Modulated by Protein Disulfide Isomerase and S-nitrosylation of this Molecular Chaperone
    Kan Wang, Jiaqi Liu, Tao Zhong, Xiaoling Liu, Yan Zeng, Xinhua Qiao, Ting Xie, Yuzhe Chen, Yingying Gao, Bo Tang et al. · 2020 · Journal of Molecular Biology
  72. Dysregulation of Exosome Cargo by Mutant Tau Expressed in Human-induced Pluripotent Stem Cell (iPSC) Neurons Revealed by Proteomics Analyses
    Sonia Podvin, Alexander Curtis Jones, Qing Liu, Brent D. Aulston, Linnea Ransom, Janneca Ames, Gloria Shen, Christopher B. Lietz, Zhenze Jiang, Anthony John O’Donoghue et al. · 2020 · Molecular & Cellular Proteomics
  73. Photodynamic exposure of Rose-Bengal inhibits Tau aggregation and modulates cytoskeletal network in neuronal cells
    Tushar Dubey, Nalini Vijay Gorantla, Kagepura Thammaiah Chandrashekara, Subashchandrabose Chinnathambi · 2020 · Scientific Reports
  74. Early detection of Alzheimer's disease using creatine chemical exchange saturation transfer magnetic resonance imaging
    Lin Chen, Peter C.M. van Zijl, Zhiliang Wei, Hanzhang Lu, Wenzhen Duan, Philip C. Wong, Tong Li, Jiadi Xu · 2021 · NeuroImage
  75. Evidence for a common pathway linking neurodegenerative diseases
    Joshua M Shulman, Philip L. De Jager · 2009 · Nature Genetics
  76. Alzheimer’s disease AdvaxCpG- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
    Hayk Davtyan, Karen Zagorski, Harinda Rajapaksha, Armine Hovakimyan, Arpine Davtyan, Irina Petrushina, Konstantin Kazarian, David H. Cribbs, Nikolai Petrovsky, Michael G. Agadjanyan et al. · 2016 · Scientific Reports
  77. Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
    Long Wang, Xindong Shui, Yuelin Diao, Duoting Chen, Ying Zhou, Tae Ho Lee · 2023 · International Journal of Molecular Sciences
  78. Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice
    Sagar Gaikwad, Nicha Puangmalai, Minal Sonawane, Mauro Montalbano, Rachel Price, Malini S. Iyer, Anamika Ray, Sandra Moreno, Rakez Kayed · 2024 · Science Translational Medicine
  79. Transgenic models of Alzheimer's disease: Better utilization of existing models through viral transgenesis
    Thomas L Platt, Valerie L. Reeves, Michael Paul Murphy · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  80. Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies
    Kurt R. Brunden, Carlo Ballatore, Virginia M.‐Y. Lee, Amos B. Smith, John Q. Trojanowski · 2012 · Biochemical Society Transactions
  81. Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer’s Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    Saurabh Kumar Jha, Niraj Kumar Jha, Dhiraj Kumar, Renu Sharma, Abhishek Shrivastava, Rashmi K. Ambasta, Pravir Kumar · 2016 · Journal of Alzheimer s Disease
  82. Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation
    Corrigan, Frances, Arulsamy, Alina, Collins-Praino, Lyndsey E., Holmes, Joshua L., Vink, Robert · 2017 · Brain, Behavior, and Immunity
  83. Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases
    Kwang Hun Lim · 2019 · Frontiers in Molecular Neuroscience
  84. Regional Variation of Splicing QTLs in Human Brain
    Yida Zhang, Harry Taegyun Yang, Kathryn E. Kadash-Edmondson, Yang Pan, Zhicheng Pan, Beverly L. Davidson, Yi Xing · 2020 · The American Journal of Human Genetics
  85. Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study
    Valentina Cecarini, Laura Bonfili, Olee Gogoi, Solomon Lawrence, Franco Maria Venanzi, Vasco Azevedo, Pamela Del Carmen Mancha-Agresti, Mariana Martins Drumond, Giacomo Rossi, Sara Berardi et al. · 2020 · Aging
  86. Genetic Mouse Models of Neurodegenerative Diseases
    Alzbeta Kralova Trancikova, David Ramonet, Darren J. Moore · 2011 · Progress in molecular biology and translational science
  87. An impedimetric microelectrode-based array sensor for label-free detection of tau hyperphosphorylation in human cells
    Heinz‐Georg Jahnke, Andrée Rothermel, Ina Sternberger, Till G.A. Mack, Randy Kurz, Oliver Pänke, Frank Striggow, Andrea Anneliese Robitzki · 2009 · Lab on a Chip
  88. Neuropathology of the Alzheimer's continuum: an update
    K. A. Jellinger · 2020 · Free Neuropathology
  89. ER‐mitochondria contacts and cholesterol metabolism are disrupted by disease‐associated tau protein
    Leonora Szabo, Nadia Cummins, Paolo Paganetti, Alex Odermatt, Andreas Papassotiropoulos, Celeste M M. Karch, Jürgen Götz, Anne Eckert, Amandine Grimm · 2023 · EMBO Reports
  90. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update
    Kelly R. Bales · 2012 · Expert Opinion on Drug Discovery
  91. Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats is Associated with Cognitive Impairment
    Dantao Peng, Xiuqing Pan, Ju Cui, Yueqin Ren, Jiewen Zhang · 2013 · Cellular Physiology and Biochemistry
  92. Self-involvement modulates the effective connectivity of the autobiographical memory network
    Keely A. Muscatell, Donna Rose Addis, Elizabeth A. Kensinger · 2009 · Social Cognitive and Affective Neuroscience
  93. An effective treatment for Alzheimer's disease must consider both amyloid and tau
    Claire J. Lansdall · 2014 · Bioscience Horizons The International Journal of Student Research
  94. 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment
    Jan Korábečný, Martin Andrš, Eugenie Nepovimová, Rafael Doležal, Katerina Babkova, Anna Horova, David Maliňák, Eva Mezeiová, Lukáš Górecki, Vendula Šepsová et al. · 2015 · Molecules
  95. Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes
    Lihua Lu, Hai‐Jing Zhong, Modi Wang, See‐Lok Ho, Hung‐Wing Li, Chung‐Hang Leung, Dik‐Lung Ma · 2015 · Scientific Reports
  96. Multi-Vitamin B Supplementation Reverses Hypoxia-Induced Tau Hyperphosphorylation and Improves Memory Function in Adult Mice
    Lixia Yu, Yuan Chen, Wei‐Guang Wang, Zhong-hai Xiao, Yan Hong · 2016 · Journal of Alzheimer s Disease
  97. Generation of a New Tau Knockout (tau Δex1 ) Line Using CRISPR/Cas9 Genome Editing in Mice
    Daniel C. S. Tan, Sherilyn Yao, Arne Ittner, Josefine Bertz, Yazi Diana Ke, Lars Matthias Ittner, Fabien Delerue · 2018 · Journal of Alzheimer s Disease
  98. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
    Bin Zhang, Yuemang Yao, Anne‐Sophie Cornec, Killian Oukoloff, Michael J. James, Pyry P. Koivula, John Q. Trojanowski, Amos B. Smith, Virginia M.‐Y. Lee, Carlo Ballatore et al. · 2018 · Molecular Neurodegeneration
  99. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles
    Anurag Kumar Singh, Gaurav Mishra, Anand Maurya, Rajendra Awasthi, Komal Kumari, Abhimanyu Thakur, Arati Rai, Gopal Kumar Rai, Bhupesh Sharma, Giriraj Thirupathirao Kulkarni et al. · 2019 · Current Alzheimer Research
  100. Genetic Dissection of Alzheimer’s Disease Using Drosophila Models
    Young‐Jae Jeon, Jaeha Lee, Byoungyun Choi, So-Yoon Won, Kyoung Sang Cho · 2020 · International Journal of Molecular Sciences